Trial Profile
A Randomized, Open-label Phase 2 Study to Evaluate the Efficacy and Safety of a Single Dose of Oral AZD0914 Compared to Intramuscular Ceftriaxone in the Treatment of Male and Female Subjects With Uncomplicated Gonorrhea
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Zoliflodacin (Primary) ; Ceftriaxone
- Indications Gonorrhoea
- Focus Adverse reactions; Therapeutic Use
- 08 Nov 2018 Results published in the New England Journal of Medicine
- 07 Nov 2018 According to an Entasis Therapeutics media release, results from the study have been published in The New England journal of Medicine (NEJM).
- 07 Nov 2018 Results presented in an Entasis Therapeutics media release.